TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 132 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $128 | -34.4% | 3,013 | -35.5% | 0.00% | -50.0% |
| Q4 2023 | $195 | +38.3% | 4,673 | +24.5% | 0.00% | 0.0% |
| Q3 2023 | $141 | -99.9% | 3,752 | +44.8% | 0.00% | -33.3% |
| Q4 2017 | $271,000 | -52.1% | 2,592 | -48.4% | 0.00% | -40.0% |
| Q3 2017 | $566,000 | -34.5% | 5,026 | -34.8% | 0.01% | -37.5% |
| Q2 2017 | $864,000 | -6.4% | 7,709 | -2.6% | 0.01% | 0.0% |
| Q1 2017 | $923,000 | +10.9% | 7,917 | +0.2% | 0.01% | +14.3% |
| Q4 2016 | $832,000 | -43.4% | 7,905 | -40.6% | 0.01% | -53.3% |
| Q3 2016 | $1,470,000 | +27.2% | 13,298 | +67.5% | 0.02% | +87.5% |
| Q2 2016 | $1,156,000 | -3.1% | 7,940 | -4.7% | 0.01% | -11.1% |
| Q1 2016 | $1,193,000 | -1.0% | 8,330 | +6.8% | 0.01% | 0.0% |
| Q4 2015 | $1,205,000 | – | 7,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 650,089 | $27,954 | 12.84% |
| Analyst IMS Investment Management Services Ltd. | 13,557 | $583 | 0.02% |
| LRI Investments, LLC | 2,000 | $85,778 | 0.01% |
| Gladius Capital Management LP | 761 | $32,701 | 0.00% |
| RHUMBLINE ADVISERS | 12,625 | $542,490 | 0.00% |
| Lindbrook Capital, LLC | 142 | $6,102 | 0.00% |
| Covestor Ltd | 26 | $1 | 0.00% |
| Red Tortoise LLC | 40 | $1,719 | 0.00% |
| OSAIC HOLDINGS, INC. | 199 | $8,551 | 0.00% |
| Parallel Advisors, LLC | 19 | $816 | 0.00% |